IQVIA HOLDINGS INC. Long-Term Debt, Maturity, after Year Five
IQVIA HOLDINGS INC. (IQV) had Long-Term Debt, Maturity, after Year Five of $3.87 billion as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive · last filed 2026-02-17
- 2025-12-31: Long-Term Debt, Maturity, after Year Five $3.87B.
- 2024-12-31: Long-Term Debt, Maturity, after Year Five $1.91B.
- 2023-12-31: Long-Term Debt, Maturity, after Year Five $4.17B.
- 2022-12-31: Long-Term Debt, Maturity, after Year Five $2.50B.
| Period end | Long-Term Debt, Maturity, after Year Five |
|---|---|
| 2025-12-31 | $3.87B 10-K · filed 2026-02-17 |
| 2024-12-31 | $1.91B 10-K · filed 2025-02-13 |
| 2023-12-31 | $4.17B 10-K · filed 2024-02-15 |
| 2022-12-31 | $2.50B 10-K · filed 2023-02-15 |
| 2021-12-31 | $3.74B 10-K · filed 2022-02-16 |
| 2020-12-31 | $3.90B 10-K · filed 2021-02-12 |
| 2020-09-30 | $8.22B 10-Q · filed 2020-10-22 |
| 2020-06-30 | $8.02B 10-Q · filed 2020-07-23 |
| 2020-03-31 | $7.16B 10-Q · filed 2020-04-30 |
| 2019-12-31 | $7.22B 10-K · filed 2020-02-18 |
| 2019-09-30 | $9.59B 10-Q · filed 2019-11-01 |
| 2019-06-30 | $8.99B 10-Q · filed 2019-07-24 |
| 2019-03-31 | $7.83B 10-Q · filed 2019-05-02 |
| 2018-12-31 | $7.92B 10-K · filed 2019-02-19 |
| 2018-09-30 | $9.97B 10-Q · filed 2018-10-25 |
| 2018-06-30 | $10.05B 10-Q · filed 2018-07-27 |
| 2018-03-31 | $8.12B 10-Q · filed 2018-05-04 |
| 2017-09-30 | $7.97B 10-Q · filed 2017-10-27 |
| 2017-06-30 | $6.95B 10-Q · filed 2017-08-04 |
| 2017-03-31 | $6.69B 10-Q · filed 2017-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |